PATH | VRL
Menu

Potential Impact of Accelerating the Primary Dose of Pneumococcal Conjugate Vaccine in Infants

This article, published in Archives of Pediatrics and Adolescent Medicine, estimates the potential effect of the acceleration of administration of the first dose of pneumococcal conjugate vaccine from two months to six weeks of age. The study concludes that this acceleration could reduce the burden of invasive pneumococcal disease among infants. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)

Author: Stancil JM, Peters TR, Givner LB, Poehling KA

Published: 2009

» Visit web page (English)

(Located at archpedi.ama-assn.org)

Citation: Stancil JM, Peters TR, Givner LB, Poehling KA. Potential Impact of Accelerating the Primary Dose of Pneumococcal Conjugate Vaccine in Infants. Archives of Pediatrics and Adolescent Medicine. 2009;163(5):422-425.

Resource types: Peer-reviewed journal

Diseases/vaccines: Pneumococcus

Topics: Disease burden and surveillance, Disease/vaccine specific information

Regions: North America and Europe